Seminerio M[au] - Search Results

Year	Number of Results
2010	2
2011	5
2012	8
2013	9
2014	1
2015	1
2017	1
2018	1
2019	1
2020	4
2021	2
2022	5
2023	1

1

Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine.

Driessen MT, Cohen JM, Thompson SF, Patterson-Lomba O, Seminerio MJ, Carr K, Totev TI, Sun R, Yim E, Mu F, Ayyagari R. Driessen MT, et al. Among authors: seminerio mj. J Headache Pain. 2022 May 16;23(1):56. doi: 10.1186/s10194-022-01415-x. J Headache Pain. 2022. PMID: 35578182 Free PMC article. Clinical Trial.

2

Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments.

Nissan GR, Kim R, Cohen JM, Seminerio MJ, Krasenbaum LJ, Carr K, Martin V. Nissan GR, et al. Among authors: seminerio mj. J Clin Med. 2022 Jul 27;11(15):4359. doi: 10.3390/jcm11154359. J Clin Med. 2022. PMID: 35955976 Free PMC article. Review.

3

Immunogenicity of biologic therapies for migraine: a review of current evidence.

Cohen JM, Ning X, Kessler Y, Rasamoelisolo M, Campos VR, Seminerio MJ, Krasenbaum LJ, Shen H, Stratton J. Cohen JM, et al. Among authors: seminerio mj. J Headache Pain. 2021 Jan 7;22(1):3. doi: 10.1186/s10194-020-01211-5. J Headache Pain. 2021. PMID: 33413094 Free PMC article. Review.

4

Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia.

Matsumoto RR, Seminerio MJ, Turner RC, Robson MJ, Nguyen L, Miller DB, O'Callaghan JP. Matsumoto RR, et al. Among authors: seminerio mj. Pharmacol Ther. 2014 Oct;144(1):28-40. doi: 10.1016/j.pharmthera.2014.05.001. Epub 2014 May 14. Pharmacol Ther. 2014. PMID: 24836729 Free PMC article. Review.

5

Preventing adverse drug-drug interactions: a need for improved data and logistics.

Seminerio MJ, Ratain MJ. Seminerio MJ, et al. Mayo Clin Proc. 2013 Feb;88(2):126-8. doi: 10.1016/j.mayocp.2012.12.005. Mayo Clin Proc. 2013. PMID: 23374616 No abstract available.

6

Sigma-1 receptors: potential targets for the treatment of substance abuse.

Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RR. Robson MJ, et al. Among authors: seminerio mj. Curr Pharm Des. 2012;18(7):902-19. doi: 10.2174/138161212799436601. Curr Pharm Des. 2012. PMID: 22288407 Review.

7

Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunction.

Lampl C, Rapoport AM, Cohen JM, Barash S, Ramirez Campos V, Seminerio MJ, Ning X, Silberstein SD. Lampl C, et al. Among authors: seminerio mj. Eur J Neurol. 2022 Jul;29(7):2129-2137. doi: 10.1111/ene.15328. Epub 2022 Mar 29. Eur J Neurol. 2022. PMID: 35302681 Clinical Trial.

8

Benzimidazolone-based selective σ₂ receptor ligands: Synthesis and pharmacological evaluation.

Intagliata S, Alsharif WF, Mesangeau C, Fazio N, Seminerio M, Xu YT, Matsumoto RR, McCurdy CR. Intagliata S, et al. Among authors: seminerio m. Eur J Med Chem. 2019 Mar 1;165:250-257. doi: 10.1016/j.ejmech.2019.01.019. Epub 2019 Jan 9. Eur J Med Chem. 2019. PMID: 30685525 Free PMC article.

9

Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study.

Driessen MT, Cohen JM, Patterson-Lomba O, Thompson SF, Seminerio M, Carr K, Totev TI, Sun R, Yim E, Mu F, Ayyagari R. Driessen MT, et al. Among authors: seminerio m. J Headache Pain. 2022 Apr 11;23(1):47. doi: 10.1186/s10194-022-01411-1. J Headache Pain. 2022. PMID: 35410121 Free PMC article.

10

Are drug labels static or dynamic?

Seminerio MJ, Ratain MJ. Seminerio MJ, et al. Clin Pharmacol Ther. 2013 Sep;94(3):302-4. doi: 10.1038/clpt.2013.109. Clin Pharmacol Ther. 2013. PMID: 23963217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results